Wednesday, July 8, 2026

Patent intelligence · US

US 8609235

Porous ceramic material and method of producing the same

granted A61PA61P43/00
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 7
Applicant portfolio 132
Patent details — US 8609235

Quick answer

US 8609235 (Porous ceramic material and method of producing the same) is held by KURARAY CO., LTD.. Status: granted. Granted Dec 17, 2013. Expires Dec 12, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
KURARAY CO., LTD.
Grant date
Expiration
Claims
14
CPC classes
A61P, A61P43/00

More from KURARAY CO., LTD.

Related pharmaceutical patents in our USPTO index.

  1. US 12410184

    Crystalline forms of a menin inhibitor

    Kura Oncology, Inc. · Expires Sep 4, 2045

    granted
  2. US 12377026

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Expires Jul 31, 2045

    granted
  3. US 12358210

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Expires Jul 10, 2045

    granted
  4. US 12344691

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Expires Jun 26, 2045

    granted
  5. US 12214061

    Adhesive composition for dental use

    KURARAY NORITAKE DENTAL INC. · Expires Jan 30, 2045

    granted
  6. US 12208148

    Dental restorative curable composition

    KURARAY NORITAKE DENTAL INC. · Expires Jan 23, 2045

    granted
  7. US 12145888

    Zirconia molded body and pre-sintered body capable of being sintered in short time

    KURARAY NORITAKE DENTAL INC. · Expires Nov 14, 2044

    granted
  8. US 12138325

    Dental composition

    KURARAY NORITAKE DENTAL INC. · Expires Nov 7, 2044

    granted

Frequently asked questions

What is US patent 8609235?

US 8609235 (Porous ceramic material and method of producing the same) is held by KURARAY CO., LTD.. Status: granted. Granted Dec 17, 2013. Expires Dec 12, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 8609235?

KURARAY CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.

When does US 8609235 expire?

Our index shows an expiration date of Dec 12, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.